IRIS
LOSA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.062
AS - Asia 4.586
EU - Europa 4.333
SA - Sud America 975
Continente sconosciuto - Info sul continente non disponibili 254
AF - Africa 81
OC - Oceania 9
Totale 16.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.761
RU - Federazione Russa 2.373
SG - Singapore 1.623
CN - Cina 1.487
BR - Brasile 789
IT - Italia 681
HK - Hong Kong 577
SE - Svezia 497
VN - Vietnam 377
FR - Francia 210
CA - Canada 148
GB - Regno Unito 131
DE - Germania 129
BD - Bangladesh 123
IN - India 105
AR - Argentina 76
IE - Irlanda 69
MX - Messico 58
PL - Polonia 40
JP - Giappone 38
AT - Austria 34
ID - Indonesia 34
FI - Finlandia 33
EC - Ecuador 29
NL - Olanda 27
ZA - Sudafrica 25
MY - Malesia 24
TR - Turchia 24
VE - Venezuela 23
JM - Giamaica 21
IQ - Iraq 20
PH - Filippine 19
ES - Italia 18
CR - Costa Rica 17
EG - Egitto 17
MA - Marocco 17
SA - Arabia Saudita 17
CO - Colombia 16
UA - Ucraina 15
UZ - Uzbekistan 14
PK - Pakistan 13
CL - Cile 12
AE - Emirati Arabi Uniti 11
HN - Honduras 10
LT - Lituania 10
NI - Nicaragua 10
PY - Paraguay 10
RO - Romania 9
KZ - Kazakistan 8
MD - Moldavia 8
PE - Perù 8
AU - Australia 7
IR - Iran 7
UY - Uruguay 7
AZ - Azerbaigian 6
KE - Kenya 6
LB - Libano 6
NP - Nepal 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
JO - Giordania 5
PS - Palestinian Territory 5
SV - El Salvador 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
BB - Barbados 4
CH - Svizzera 4
DK - Danimarca 4
HU - Ungheria 4
IL - Israele 4
SK - Slovacchia (Repubblica Slovacca) 4
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BO - Bolivia 3
CY - Cipro 3
CZ - Repubblica Ceca 3
EE - Estonia 3
GR - Grecia 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
BG - Bulgaria 2
BH - Bahrain 2
BM - Bermuda 2
GT - Guatemala 2
KR - Corea 2
LC - Santa Lucia 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
MT - Malta 2
NG - Nigeria 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
Totale 16.025
Salva come PNG Salva come JPEG
Città #
Ashburn 760
Singapore 743
Moscow 586
Hong Kong 568
San Jose 532
Council Bluffs 470
Dallas 402
Shanghai 287
The Dalles 230
North Charleston 206
Hefei 202
Milan 201
Beijing 185
Lawrence 168
New York 168
Princeton 168
Lauterbourg 165
Ho Chi Minh City 132
Santa Clara 123
Los Angeles 107
Hanoi 88
São Paulo 76
Dublin 68
Phoenix 65
Atlanta 51
Munich 50
Las Vegas 49
Rome 46
Orem 41
Chicago 32
Miano 32
Tokyo 32
Warsaw 32
Seattle 31
Montreal 28
Washington 28
Chennai 26
Haiphong 26
Rio de Janeiro 26
Toronto 26
Boardman 25
Boston 24
Denver 24
Waynesboro 24
London 23
Nuremberg 23
Houston 22
Mexico City 22
Manchester 21
North Bergen 21
San Francisco 21
Brooklyn 20
Bologna 19
Naples 19
Guangzhou 18
Helsinki 18
Curitiba 17
Poplar 17
Belo Horizonte 16
Frankfurt am Main 16
Brasília 15
Columbus 15
Kuala Lumpur 15
Philadelphia 15
Stockholm 15
Turku 14
Amsterdam 13
Cairo 13
Campinas 13
Da Nang 13
Johannesburg 13
Mumbai 13
Pune 13
San José 13
Tashkent 13
Vienna 13
Buffalo 11
Cleveland 10
Florence 10
Guayaquil 10
Porto Alegre 10
Riyadh 10
Shenzhen 10
Turin 10
Casablanca 9
Cesano Boscone 9
Guarulhos 9
Hải Dương 9
Kingston 9
Querétaro 9
Quito 9
Salvador 9
Ankara 8
Baltimore 8
Barnet 8
Caracas 8
Charlottesville 8
Cincinnati 8
Dhaka 8
Hangzhou 8
Totale 8.102
Salva come PNG Salva come JPEG
Nome #
Cushing's disease due to double pituitary ACTH-secreting adenomas: The first case report 834
Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas 351
Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo 242
Combined characterization of a pituitary adenoma and a subcutaneous lipoma in a MEN1 patient with a whole gene deletion 195
Pituitary Surgery 191
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity 181
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 172
Craniopharyngioma 146
Asymptomatic Thyrotropin-secreting Pituitary Macroadenoma in a Thirteen Year-old Girl: Successful First-line Treatment with Somatostatin Analogues 145
Acromegaly associated with a granular cell tumor of the neurohypophysis: a clinical and histological study - Case report 140
Gamma knife radiosurgery in patients with Nelson’s syndrome 138
Benign and Malignant Tumors of the Pituitary Gland 135
Lymphocytic hypophysitis: Differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities - Report of a case and literature review 134
A conformational switch controlling the toxicity of the prion protein 130
A non-functioning pituitary adenoma initially mimicking a microprolactinoma: The case for long-term follow-up of patients with mild hyperprolactinemia? 130
Craniopharyngiomas 128
A Multicenter, Propensity Score–Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 125
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 119
Novel approach to bone comorbidity in resistant acromegaly 119
Acromegaly: surgical results and prognosis. 118
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 118
Gamma knife radiosurgery for pituitary tumors: A systematic review and meta‐analysis 118
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 114
Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis 113
AZA-Deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors 108
Acromegaly is associated with increased cancer risk: A survey in Italy 107
High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas 106
Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 106
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma 105
Intranasal oxytocin as a treatment for obesity: safety and efficacy 103
Craniopharyngioma in Pediatrics and Adults 102
Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy 102
Normal insulin-like growth factor 1 during somatostatin receptor ligand treatment predicts surgical cure in acromegaly 101
Bilateral inferior petrosal sinus sampling in adrenocorticotropin-dependent hypercortisolism: always, never, or sometimes? 98
Repeat gamma knife radiosurgery for recurrent pituitary adenomas. 95
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action 94
The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective 94
Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing 94
Complications of transsphenoidal surgery in patients with pituitary adenoma: experience at a single centre 93
Primary sellar melanocytoma: report of two cases treated at the same institution and their long-term outcome 93
Microsurgical therapy of pituitary adenomas 92
Erratum: Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors (Radiotherapy and Oncology 99 (2011) (23-28)) 91
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 91
Pituitary radiotherapy for Cushing's disease 91
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 91
The open sella technique for surgical treatment of pituitary macroadenomas: Safety and efficacy in a large clinical series 90
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 89
The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report 87
Combined insulin resistance of glucose and protein metabolism in acromegaly. 87
Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly 87
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series 84
Surgical treatment of prolactin-secreting pituitary adenomas: Early results and long-term outcome 84
D3-Growth hormone receptor polymorphism in acromegaly: Effects on metabolic phenotype 84
Role of radiosurgery in the treatment of Cushing's disease 83
Widened transnasal surgical approach for removal of huge, forward-spreading pituitary neoplasms 83
Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease 83
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement 83
Letter to the Editor. Management of residual nonfunctioning pituitary adenoma: watchful waiting or adjuvant treatment? 79
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 79
Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism 79
Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques 79
Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels RID B-6543-2008 78
Metastatic prostatic adenocarcinoma presenting as a pituitary mass: Shrinkage of the lesion and clinical improvement with medical treatment 78
Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas RID B-6543-2008 78
Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. 78
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors 77
Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas 77
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. 77
Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors - Comparison between micro- and macroadenomas 77
Endocrine inactive and gonadotroph adenomas: diagnosis and management 76
Asymptomatic internal carotid artery occlusion after gamma knife radiosurgery for pituitary adenoma: Report of two cases and review of the literature 76
Proliferation index of nonfunctioning pituitary adenomas: Correlations with clinical characteristics and long-term follow-up results 75
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer 75
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations 74
Combined insulin resistance of glucose and protein metabolism in acromegaly 73
Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease. 73
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma 73
Food intake regulating hormones in adult craniopharyngioma patients 73
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 73
Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas 72
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 71
The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas 71
Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment 71
Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors 71
Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing's disease from metabolic syndrome 71
Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency 71
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients 71
Non-functioning pituitary adenoma database: A useful resource to improve the clinical management of pituitary tumors 71
Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas 70
Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016 70
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 70
Primary sellar melanocytoma: pathological, clinical and treatment review 70
Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy 69
Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly 69
Predictors of morbidity and mortality in acromegaly: An Italian survey 69
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 69
Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients 69
Longitudinal splitting of optic pathways by non-functioning pituitary macroadenoma: report of two cases. 68
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 68
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour. 68
Totale 10.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.852
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202286 0 0 0 49 7 1 13 3 1 2 1 9
2022/2023939 364 169 87 39 10 100 70 74 20 2 1 3
2023/2024491 18 5 40 37 46 140 6 39 3 17 26 114
2024/20252.492 359 62 15 77 68 234 371 163 418 312 187 226
2025/20269.168 602 786 734 1.122 557 790 820 563 2.155 456 288 295
2026/20272.956 466 837 789 864 0 0 0 0 0 0 0 0
Totale 16.300